BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10921928)

  • 1. The Pit-1beta domain dictates active repression and alteration of histone acetylation of the proximal prolactin promoter.
    Diamond SE; Gutierrez-Hartmann A
    J Biol Chem; 2000 Oct; 275(40):30977-86. PubMed ID: 10921928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pit-1beta reduces transcription and CREB-binding protein recruitment in a DNA context-dependent manner.
    Ferry AL; Locasto DM; Meszaros LB; Bailey JC; Jonsen MD; Brodsky K; Hoon CJ; Gutierrez-Hartmann A; Diamond SE
    J Endocrinol; 2005 Apr; 185(1):173-85. PubMed ID: 15817838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 26-amino acid insertion domain defines a functional transcription switch motif in Pit-1beta.
    Diamond SE; Gutierrez-Hartmann A
    J Biol Chem; 1996 Nov; 271(46):28925-32. PubMed ID: 8910541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic mechanisms in the dopamine D2 receptor-dependent inhibition of the prolactin gene.
    Liu JC; Baker RE; Chow W; Sun CK; Elsholtz HP
    Mol Endocrinol; 2005 Jul; 19(7):1904-17. PubMed ID: 15731170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ras signaling and transcriptional synergy at a flexible Ets-1/Pit-1 composite DNA element is defined by the assembly of selective activation domains.
    Duval DL; Jean A; Gutierrez-Hartmann A
    J Biol Chem; 2003 Oct; 278(41):39684-96. PubMed ID: 12902343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Pit-1 homeodomain and beta-domain interact with Ets-1 and modulate synergistic activation of the rat prolactin promoter.
    Bradford AP; Brodsky KS; Diamond SE; Kuhn LC; Liu Y; Gutierrez-Hartmann A
    J Biol Chem; 2000 Feb; 275(5):3100-6. PubMed ID: 10652292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dermo-1, a multifunctional basic helix-loop-helix protein, represses MyoD transactivation via the HLH domain, MEF2 interaction, and chromatin deacetylation.
    Gong XQ; Li L
    J Biol Chem; 2002 Apr; 277(14):12310-7. PubMed ID: 11809751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The zinc finger Ikaros transcription factor regulates pituitary growth hormone and prolactin gene expression through distinct effects on chromatin accessibility.
    Ezzat S; Yu S; Asa SL
    Mol Endocrinol; 2005 Apr; 19(4):1004-11. PubMed ID: 15618287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 26-amino acid beta-motif of the Pit-1beta transcription factor is a dominant and independent repressor domain.
    Jonsen MD; Duval DL; Gutierrez-Hartmann A
    Mol Endocrinol; 2009 Sep; 23(9):1371-84. PubMed ID: 19556346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reconstitution of the protein kinase A response of the rat prolactin promoter: differential effects of distinct Pit-1 isoforms and functional interaction with Oct-1.
    Diamond SE; Chiono M; Gutierrez-Hartmann A
    Mol Endocrinol; 1999 Feb; 13(2):228-38. PubMed ID: 9973253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pit-1 binding to specific DNA sites as a monomer or dimer determines gene-specific use of a tyrosine-dependent synergy domain.
    Holloway JM; Szeto DP; Scully KM; Glass CK; Rosenfeld MG
    Genes Dev; 1995 Aug; 9(16):1992-2006. PubMed ID: 7649480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repression of the prolactin promoter: a functional consequence of the heterodimerization between Pit-1 and Pit-1 beta.
    Sporici RA; Hodskins JS; Locasto DM; Meszaros LB; Ferry AL; Weidner AM; Rinehart CA; Bailey JC; Mains IM; Diamond SE
    J Mol Endocrinol; 2005 Oct; 35(2):317-31. PubMed ID: 16216912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A composite Ets/Pit-1 binding site in the prolactin gene can mediate transcriptional responses to multiple signal transduction pathways.
    Howard PW; Maurer RA
    J Biol Chem; 1995 Sep; 270(36):20930-6. PubMed ID: 7673116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergy between deacetylase inhibitors and IL-1beta in activation of the serum amyloid A2 gene promoter.
    Blais M; Désilets A; Asselin C
    DNA Cell Biol; 2005 Apr; 24(4):209-17. PubMed ID: 15812237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoration of transforming growth factor-beta signaling through receptor RI induction by histone deacetylase activity inhibition in breast cancer cells.
    Ammanamanchi S; Brattain MG
    J Biol Chem; 2004 Jul; 279(31):32620-5. PubMed ID: 15155736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tal1/SCL binding to pericentromeric DNA represses transcription.
    Wen J; Huang S; Pack SD; Yu X; Brandt SJ; Noguchi CT
    J Biol Chem; 2005 Apr; 280(13):12956-66. PubMed ID: 15677454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An alternatively spliced Pit-1 isoform altered in its ability to trans-activate.
    Morris AE; Kloss B; McChesney RE; Bancroft C; Chasin LA
    Nucleic Acids Res; 1992 Mar; 20(6):1355-61. PubMed ID: 1561093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression cloning and characterization of PREB (prolactin regulatory element binding), a novel WD motif DNA-binding protein with a capacity to regulate prolactin promoter activity.
    Fliss MS; Hinkle PM; Bancroft C
    Mol Endocrinol; 1999 Apr; 13(4):644-57. PubMed ID: 10194769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inhibition of prolactin gene transcription by the ETS-2 repressor factor.
    Day RN; Liu J; Sundmark V; Kawecki M; Berry D; Elsholtz HP
    J Biol Chem; 1998 Nov; 273(48):31909-15. PubMed ID: 9822660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methyltransferase 1 knock down induces gene expression by a mechanism independent of DNA methylation and histone deacetylation.
    Milutinovic S; Brown SE; Zhuang Q; Szyf M
    J Biol Chem; 2004 Jul; 279(27):27915-27. PubMed ID: 15087453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.